How much does a box of Acemini cost?

Asciminib (Asciminib) is a third-generation tyrosine kinase inhibitor (TKI) specifically used to treat chronic myelogenous leukemia (CML). Unlike earlier TKI drugs, aceminib works by acting on ABL1kinase's "myristoyl" The pan>pocket is inhibited. This mechanism makes it more effective against some common TKI resistance mutations, especially the T315I mutation. It blocks the proliferation of leukemia cells and shows good efficacy and tolerability in patients who have failed previous generations of TKIs. Therefore, aceminib has become a new hope for CML patients, especially drug-resistant patients.

Regarding the price of Aceminib, since it has not yet been launched in mainland China, patients are currently unable to purchase the drug through domestic pharmacies or hospitals. If patients need to use acemini, they must purchase it through overseas channels. Internationally, the original drug of Asiminib is mainly produced by European pharmaceutical companies, and the price is relatively high, usually around tens of thousands of yuan per box. This price is a heavy burden for many patients.

However, with the emergence of generic drugs, patients have a relatively economical choice. Generic drugs produced in Laos are one of the common choices at present, and the price is relatively cheap, about more than 4,000 yuan per box. Although generic drugs are low in price, their pharmaceutical ingredients are basically the same as those of the original drugs, and their therapeutic effects and safety are basically at a similar level. Therefore, for patients with limited financial conditions, Laotian generic drugs have become a cost-effective option.

Overall, as a therapeutic drug for CML, aceminib has significant efficacy, especially in the face of TKI resistance. However, their high prices make generic drugs a realistic choice for many patients, helping more patients obtain effective treatment.